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Prenatal exposures may have a distinct impact for long-term health, one example being ex-
posure to maternal ‘diabesity’ during pregnancy increasing offspring ‘diabesity’ risk. Malpro-
gramming of the central nervous regulation of body weight, food intake and metabolism has
been identified as a critical mechanism. While concrete disrupting factors still remain un-
clear, growing focus on acquired epigenomic alterations have been proposed. Due to the in-
dependent development from the mother, the chicken embryo provides a valuable model to
distinctively establish causal factors and mechanisms.
Aim
The aim of this study was to determine the effects of prenatal hyperglycemia on postnatal
hypothalamic gene expression and promoter DNA methylation in the chicken.
Methods and Findings
To temporarily induce high-glucose exposure in chicken embryos, 0.5 ml glucose solution
(30 mmol/l) were administered daily via catheter into a vessel of the chorioallantoic egg
membrane from days 14 to 17 of incubation. At three weeks of postnatal age, body weight,
total body fat, blood glucose, mRNA expression (INSR, LEPR,GLUT1, GLUT3) as well as
corresponding promoter DNA methylation were determined in mediobasal hypothalamic
brain slices (Nucleus infundibuli hypothalami). Although no significant changes in morpho-
metric and metabolic parameters were detected, strongly decreased mRNA expression
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occurred in all candidate genes. Surprisingly, however, no relevant alterations were ob-
served in respective promoter methylation.
Conclusion
Prenatal hyperglycemia induces strong changes in later hypothalamic expression of INSR,
LEPR,GLUT1, andGLUT3mRNA. While the chicken provides an interesting approach for
developmental malprogramming, the classical expression regulation via promoter methyla-
tion was not observed here. This may be due to alternative/interacting brain mechanisms or
the thus far under-explored bird epigenome.
Introduction
Overweight and obesity are continuously increasing in epidemic-like proportions as are the
downstream health risks associated with developing diabetes and alterations typical for the
Metabolic Syndrome [1, 2]. It is more and more accepted that early life maternal and other en-
vironmental experiences have distinct impact for the long-term offspring health through ‘pro-
gramming/malprogramming’ of body functions during ‘critical periods’ of perinatal life [3, 4].
During neuronal development, hyperglycemia (e.g. through gestational diabetes) may cause
long-lasting malprogramming of the central nervous regulation of body weight, food intake
and metabolism, resulting in an increased ‘diabesity’ risk [5, 6]. Still unclear are the basic mech-
anisms behind perinatal 'malprogramming', made more challenging with the lack of animal
models available to decipher singular risk factors irrespective of potential confounders and var-
iables, as unavoidable in the complex placental mammalian mother-fetus-environment-
interaction.
Because of its nearly ‘unaffected’ embryonic development, independently from the mother,
the chicken provides an excellent model for investigations of pre- and perinatal developmental
processes [7–9]. It allows highly standardized and controlled manipulations of pre- and perina-
tal environmental factors during distinct time windows of embryonic development. Physiologi-
cal developmental pattern during late prenatal period of the chicken have similarity to that in
mammals and human fetuses [9]. Recently there have been a growing number of respective
studies involving chicken [10–16], especially with the availability and improved annotation of
the chicken sequence/genome [17]. Furthermore, the chicken shows similar developmental
modes and causes of obesity and related metabolic disorders [18–20]. Beyond genetic predispo-
sitions, environmental factors may induce disruption in the glucose-insulin-balance and in-
creased adiposity in the chicken, too [21, 22].
Interestingly, the neuroendocrine regulation of energy balance in birds and mammals is also
very similar [23, 24]. While in mammals, the mediobasal Nucleus arcuatus hypothalami (ARC)
integrates hormonal and metabolic signals from the periphery, especially insulin, leptin, and
glucose, to regulate metabolism, food intake and body weight [25, 26], its structural and func-
tional equivalent in birds is the Nucleus infundibuli hypothalami (NI) [27, 28]. Insulin receptor
(INSR), leptin receptor (LEPR) as well as glucose transporters (GLUT) have been identified in
bird NI accordingly [10, 14, 29–33]. In mammals, persisting molecular as well as functional hy-
pothalamic resistance to insulin and leptin were observed in consequence of perinatal overfeed-
ing and, especially, materno-fetal hyperglycemia, obviously predisposing to lasting increased
‘diabesity’ risk [34–38]. Interestingly, more recent observations indicate that perinatally ac-
quired alterations of respective promoter DNAmethylation may contribute to this
Prenatal Hyperglycemia and Hypothalamic Malprogramming
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developmental malprogramming [39–42]. However, concrete causal and ‘disruptive’ factors
remain unknown.
Therefore, this study was carried out to determine effects of prenatal high-glucose exposure
on the postnatal hypothalamic expression of INSR, LEPR, and glucose transporters (GLUT1
and GLUT3) in prenatally glucose-treated chickens as compared to NaCl-injected controls,




All animal procedures were performed in accordance with the European Communities Council
Directive (86/609/EEC) and were approved by the local animal welfare committee (G 0275/09;
Lageso Berlin, Germany).
Animal model and study design
Experiments were carried out in three-week-old juvenile chickens (Gallus gallus f. domestica),
hatched from eggs incubated prenatally under different metabolic conditions. Eggs were ob-
tained for research approaches from a commercial breeder (Lohmann Tierzucht GmbH, Cux-
haven, Germany). In the course of the 21 days of embryonic (‘fetal’) development, the eggs
were incubated under standard conditions (temperature of 37.5°C, relative air humidity 70% to
90% during hatching period, and automatic turning). During days 14 to 17 of incubation, a
‘critical period’ in the development of the neuro-endocrine system of chicken embryos [9], the
eggs were divided into two groups; injected daily with either 0.5 ml 0.9% NaCl solution (NaCl-
treated control group, NaCl) or with 0.5 ml of a highly-concentrated glucose solution (30
mmol/l D(+) Glucose, Carl-Roth GmbH, Germany) to induce hyperglycemia in chicken em-
bryos (glucose-treated group, Glc). For induction of hyperglycemia this high concentration
was used because normal avian blood glucose level is approximately double that of healthy
mammals [43]. Injections were applied via a catheter (BD Valu Set, needle Ø 27G) fixed on the
eggshell and inserted into a vessel of the chorioallantoic membrane through a small square
hole (3 mm each side), drilled to reach the blood vessel under the egg shell. After catheteriza-
tion the hole was closed with dental wax (Pluradent AG & Co KG).
Chickens from both groups were held in identical environmental and alimentary conditions
(ambient temperature of 25°C with relative air humidity of 30%) during three weeks after
hatching. An infrared lamp was an additional source of heat (35°C) for the chicks until day 14
post hatching. Food (complete feed, ssniff Spezialdiäten, Soest, Germany) and water were pro-
vided ad libitum to all animals.
Body weight, fat and blood glucose
Post hatching, body weight was measured during three weeks until the day of experimental ap-
proach. At day of sacrifice (21.3 ± 0.2, n = 100), the birds were decapitated and blood and tissue
samples were collected. Blood glucose was measured photometrically using the glucoseoxidase-
peroxidase method (Dr Lange GmbH, Berlin, Germany). Body fat content was evaluated by
drying the carcass mass (minus the stomach and intestine) to constant weight, followed by
whole-body chloroform extraction in a Soxhlet apparatus [44]. Body fat was calculated as per-
centage of carcass mass.
Prenatal Hyperglycemia and Hypothalamic Malprogramming
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Sample preparation
For molecular biology analyses, the Nucleus infundibuli hypothalami (NI) was micro-dissected
from deep frozen brain slices [45]. Genomic DNA and total RNA were simultaneously isolated
from the NI brain probe using the ZR-Duet DNA/RNAMiniPrep Kit (Zymo Research, Irvine,
CA, USA) according to the manufacturer’s instructions. cDNA was synthesized from total
RNA according to the manufacturer’s protocol of the iScript cDNA Synthesis Kit (BioRad,
Hercules, CA, USA), reverse transcriptase minus (RT-) negative controls were included. Geno-
mic DNA was bisulfite treated using the EZ DNAMethylation-Gold Kit (Zymo Research) fol-
lowing manufacturer’s protocol.
Gene expression analysis
Quantitative real-time PCR (qPCR) was used to measure the relative mRNA expression for the
genes: insulin receptor (INSR), leptin receptor (LEPR), and glucose transporter 1 and 3
(GLUT1, GLUT3). Commercially available TaqMan probe-based gene expression assays were
used (Life Technologies) and were run on an Applied Biosystems 7500 instrument according
to the manufacturer’s protocol. Expression levels were normalized to the housekeeping gene
BETA ACTIN. When possible exon-spanning primer sets were selected and qPCR was per-
formed as duplex qPCR with housekeeping gene. Expression assays were performed in tripli-
cate and relative gene expression of target genes was calculated using the 2-ΔCT method
corrected for the amplification efficiency calculated from standard curves of each primer set
[45, 46]. TaqMan gene expression assays: INSR: Gg03330786_m1, LEPR: Gg03347016_m1,
GLUT1: Gg03367103_m1, GLUT3: Gg03349364_m1 (all FAM-labeled), and BETA ACTIN:
Gg03815934_s1, VIC-labeled, primer limited.
DNAmethylation assays
Amplicon regions for pyrosequencing analyses were chosen using UCSC genome browser
(build: Chicken Nov. 2011, ICGSC Gallus_gallus-4.0/galGal4) based on the proximity of a
CpG island to the transcriptional start site, the number of CpG sites and obtaining optimal
PCR amplification and sequencing conditions. CpG islands annotated in UCSC browser were
further confirmed with CpGPlot (http://www.ebi.ac.uk/Tools/seqstats/emboss_cpgplot/).
Methylation assays were designed using the PyroMark Assay Design Software 2.0 (Qiagen, Va-
lencia, CA, USA, www.qiagen.com). Bisulfite-converted DNA was mixed with 0.2 μM of each
primer and amplified using HotStarTaq plus Master Mix (Qiagen) or ZymoTaq (Zymo Re-
search) following standard procedures. Pyrosequencing was run on amplified PCR products
using the Pyromark Q24 pyrosequencer (Qiagen). Percent methylation was individually ana-
lyzed across all individual CpG sites located within the following promoters/CpG island re-
gions of interest: INSR (14 CpG sites), LEPR (7 CpG sites), GLUT1 promoter (11 CpG sites),
and GLUT3 promoter (6 CpG sites). Each assay included a bisulfite conversion check to verify
full conversion of the DNA and assays were validated with a methylation scale (0–100%). Prim-
er sequences and pyrosequencing assay information are given in Table 1.
Statistical analyses
Investigations were part of a larger approach on metabolic, hormonal, morphometric, neuroe-
lectrophysiological, and neurogenetic outcomes in prenatally glucose-treated chickens. For
each parameter, obtained from randomly selected animals, the highest available number of
sample measurements is presented here.
Prenatal Hyperglycemia and Hypothalamic Malprogramming
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The baseline parameters (body weight, fat content and blood glucose) were calculated as
means ± SEM. Real-time data are given as arbitrary units. For statistical analyses of the investi-
gated peripheral parameters, real-time expression and pyrosequencing methylation data con-
cerning differences between experimental groups Student´s t-test for independent samples (if
normally distributed) or Mann-Whitney U-test (if not normally distributed) were used. Nor-
mal distribution of the data was tested before all statistical procedures using the Kolmogoroff-
Smirnoff-Test. Differences in sex ratio were tested with chi-square test. Methylation and ex-
pression data were stratified by sex to determine any sex-specific effects. For analyses of rela-
tions between two variables, Spearman’s rank correlation test was performed overall and
by groups.
Significance level was set at p<0.05. All statistical tests were carried out with GraphPad
Prism (Version 4.03, San Diego, California, USA) and IBM SPSS for windows (Version 19.0,
Munich, Germany), respectively.
Results
Body weight, fat and blood glucose
Body weight was measured at different time points of postnatal development and no significant
differences were seen between groups during the entire observational period (Table 2). Accord-
ingly, no difference was observed in total body fat content at day 21 between the NaCl-treated
control group and the prenatally glucose-treated group (Table 2). Also, on day 21 of life, blood
glucose levels did not differ between both groups (Table 2).
Table 2. Baseline characteristics, hypothalamic mRNA gene expression and overall promoter methylation in three-week-old chickens.
Variables Prenatally NaCl-treated group Prenatally glucose-treated group p-value
Sex ratio (M/F in %) 28/72 36/64 0.532*
Age at sacriﬁce (days) 21.1 ± 0.2 (39) 21.4 ± 0.2 (61) 0.285
Body weight development (g)
day 1 41.3 ± 0.7 (39) 42.7 ± 0.6 (61) 0.133
day 7 69.3 ± 1.1 (39) 67.7 ± 1.3 (61) 0.385
day 14 142.2 ± 2.5 (39) 137.6 ± 2.4 (61) 0.201
day of sacriﬁce 239.7 ± 4.1 (39) 238.3 ± 5.1 (61) 0.865
Body fat content at day of sacriﬁce (%) 8.2 ± 0.2 (15) 7.8 ± 0.2 (23) 0.200
Blood glucose at day of sacriﬁce (mmol/l) 9.3 ± 0.3 (15) 8.8 ± 0.2 (32) 0.253
Hypothalamic mRNA gene expression (arbitrary units)
INSR 36.6 ± 3.1 (20) 25.6 ± 2.0 (25) 0.006
LEPR 0.45 ± 0.04 (20) 0.33 ± 0.02 (25) 0.046
GLUT1 427.6 ± 75.0 (20) 224.3 ± 28.6 (25) 0.006
GLUT3 337.5 ± 46.7 (20) 229.1 ± 29.4 (25) 0.047
Hypothalamic promoter region methylation (%)
INSR 71.4 ± 0.9 (22) 70.9 ± 1.0 (26) 0.673
LEPR 0.7 ± 0.1 (19) 0.6 ± 0.1 (20) 0.432
GLUT1 11.9 ± 0.3 (22) 10.4 ± 0.6 (26) 0.100
GLUT3 1.4 ± 0.1 (20) 1.6 ± 0.1 (25) 0.187
Values are expressed as means ± SEM. Number of animals in parenthesis.
p-values were calculated using Student’s t-test or Mann-Whitney U-test when appropriate.
*chi-square test
Abbreviations: GLUT, glucose transporter; INSR, insulin receptor, LEPR, leptin receptor; M/F, males/females
doi:10.1371/journal.pone.0119213.t002
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Gene expression analysis
As an experimental precondition [47], we first verified that mRNA expression of the house-
keeping gene BETA ACTIN was unaffected by respective prenatal treatment. Prenatal glucose
treatment did not lead to changes of BETA ACTINmRNA expression in the Nucleus infundi-
buli hypothalami (NI) (Fig. 1).
However, three-week-old chickens prenatally treated with glucose showed a significant re-
duction of INSR and LEPRmRNA by approximately one-third as compared with prenatally
NaCl-treated controls (all p<0.05, Table 2, Fig. 1). Additionally, both expression levels of
GLUT1mRNA as well as GLUT3mRNA were significantly reduced in the prenatally glucose-
exposed group (Table 2, Fig. 1).
DNAmethylation assays
Investigations at the promoter regions of the genes of interest showed no disruption of methyl-
ation levels occurred due to prenatal high-glucose exposure, neither in total percentage of pro-
moter DNAmethylation (Table 2) nor at single CpG sites (Figs. 2–5). A weak but statistically
significant difference according to group was found only at one out of a total of 38 CpG sites
Fig 1. mRNA expression in theNucleus infundibuli hypothalami (NI) in three-week-old chickens.Relative gene expression of insulin receptor (INSR),
leptin receptor (LEPR), and glucose transporters 1 and 3 (GLUT1,GLUT3), all normalized to BETA ACTIN. Data are given as means ± SEM, shown as
percentage of prenatally NaCl-treated controls. * p<0.05 (Mann-Whitney U-test)
doi:10.1371/journal.pone.0119213.g001
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investigated per animal, (CpG site 8 in GLUT1: NaCl: 19.8% ± 0.5 vs. Glc: 16.5% ± 1.0, p<0.05,
Fig. 4).
Correlation analyses and sex specific observations
The expression of glucose transporter genes, GLUT1 and GLUT3, showed positive overall cor-
relation (r = 0.654, p<0.0001). Interestingly, GLUT1 and GLUT3 expression also showed posi-
tive overall correlation with LEPR expression (r = 0.530, p = 0.0002; r = 0.553, p<0.0001,
respectively). Similarly, GLUT1 and INSR expression were significantly positively correlated
across the cohort (r = 0.386, p<0.01) and a similar trend was also seen for GLUT3 and INSR
(r = 0.170, p = 0.265). However, none of the candidates under investigation had mRNA expres-
sion levels significantly correlating with levels of promoter methylation, neither to overall
methylation average across a pyrosequencing region (Fig. 6) or at individual CpG sites.
Fig 2. Insulin receptor (INSR). Schematic illustration of sequence map of the insulin receptor (INSR) gene promoter region with chromosomal location of
pyroassay (A), and corresponding DNAmethylation levels at individual CpG sites for prenatally NaCl-treated controls (black) and the prenatally glucose-
treated group (gray) (B).
doi:10.1371/journal.pone.0119213.g002
Prenatal Hyperglycemia and Hypothalamic Malprogramming
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Spearman coefficients by group for methylation vs. mRNA were as follows: INSR (NaCl:
r = 0.388, Glc: r = 0.251), LEPR (NaCl: r = -0.090, Glc: r = -0.186), GLUT1 (NaCl: r = -0.022,
Glc: r = 0.101), and GLUT3 (NaCl: r = -0.159, Glc: r = -0.076; all p-values are not significant;
Fig. 6). Even methylation levels at the only altered CpG site, CpG 8 in the GLUT1 promoter re-
gion, and GLUT1mRNA expression showed no correlation (r = 0.07, p = 0.633).
Although sex ratio did not differ between groups (Table 2), we finally addressed potential
sex differences by group at the molecular level, too. Analyses of GLUT3 and LEPRmRNA ex-
pression data stratified by sex revealed no sex-specific pattern. The only statistically significant
differences in gene expression between groups and by sex were observed in males for GLUT1
(NaCl: 495.6 ± 118.4 vs. Glc: 204.4 ± 39.2) and INSR (NaCl: 40.9 ± 4.8 vs. Glc: 25.6 ± 3.3) (all
p<0.05). However, overall group differences for GLUT1 and INSR remained when adjusted for
sex. The one and only difference in methylation levels, occurring at CpG site 8 for GLUT1, was
rather linked to females (NaCl: 20.1% ± 0.5 vs. Glc: 15.3% ± 1.6, p<0.05) however, the overall
group difference was no longer significant when adjusted for sex.
Fig 3. Leptin receptor (LEPR). Schematic illustration of sequence map of the leptin receptor (LEPR) gene promoter region with chromosomal location of
pyroassay (A), and corresponding DNAmethylation levels at individual CpG sites for prenatally NaCl-treated controls (black) and the prenatally glucose-
treated group (gray) (B).
doi:10.1371/journal.pone.0119213.g003
Prenatal Hyperglycemia and Hypothalamic Malprogramming
PLOS ONE | DOI:10.1371/journal.pone.0119213 March 26, 2015 9 / 19
Discussion
There are a variety of animal models on ‘perinatal programming’, examining long-term effects
of altered intrauterine and early postnatal conditions for later health risks, especially concern-
ing diabetes and obesity. Identifying concrete causal factors, however, is rather difficult due to
the complexity of the interaction between the fetus, the maternal organism, and environmental
factors. Therefore, we aimed to investigate consequences of short-term exposure to high glu-
cose within the critical period of late prenatal development on respective postnatal hypotha-
lamic gene expression in the avian embryo model representing a unique ‘closed system’ to
examine and identify risk factors under well-controlled and highly standardized conditions.
The study demonstrates that a strong direct relationship exists between prenatal high-glucose
exposure and altered subsequent hypothalamic gene expression.
Fig 4. Glucose transporter 1 (GLUT1). Schematic illustration of sequence map of the glucose transporter 1 (GLUT1) gene promoter region with
chromosomal location of pyroassay (A), and corresponding DNAmethylation levels at individual CpG sites for prenatally NaCl-treated controls (black) and
the prenatally glucose-treated group (gray) (B).* p<0.05 (Mann-Whitney U-test)
doi:10.1371/journal.pone.0119213.g004
Prenatal Hyperglycemia and Hypothalamic Malprogramming
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In the human, it is well known that materno-fetal hyperglycemia, such as occurring in gesta-
tional diabetes (GDM), can have long lasting deleterious effects on offspring’s health. Epidemi-
ological studies have shown that offspring of mothers with diabetes during pregnancy have an
increased risk for developing diabetes, obesity and associated metabolic and cardiovascular dis-
eases later in life, even irrespective of genetic predisposition [48–50]. However, whether in-
creased glucose itself or rather accompanying alterations of lipids, amino acids and/or
hormone concentrations are responsible for acquired malprogramming of body weight regula-
tion and metabolism remain unclear. Interestingly, epidemiological studies strongly indicate a
particular dose-dependent impact of glucose/hyperglycemia for the overall outcome of off-
spring of diabetic mothers [51]. On the other hand, offspring of obese pregnant women with-
out having gestational diabetes are also at increased risk for an adverse outcome suggesting
that components other than glucose may also play a crucial role [52]. Both GDM and obesity
appear to be independently associated with adverse pregnancy outcomes, but their combina-
tion has a greater impact than one alone [52].
Fig 5. Glucose transporter 3 (GLUT3). Schematic illustration of sequence map of the glucose transporter 3 (GLUT3) gene promoter region with
chromosomal location of pyroassay (A), and corresponding DNAmethylation levels at individual CpG sites for prenatally NaCl-treated controls (black) and
the prenatally glucose-treated group (gray) (B).
doi:10.1371/journal.pone.0119213.g005
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Numerous experimental observations have shown that materno-fetal hyperglycemia in
mammals may lead to later increased disposition to hyperphagia, hyperinsulinemia, impaired
glucose tolerance and overweight in exposed offspring [36, 53, 54]. Structural and functional
malorganization of hypothalamic regulatory circuits has been identified as a key mechanism
[36, 37, 55]. Interestingly, these hypothalamic alterations were preventable by normalization of
gestational hyperglycemia [54]. Similarly, both neonatal exposure to maternal diabetes as well
as neonatal overfeeding causes a ‘malprogramming’ of hypothalamic insulinergic and leptiner-
gic pathways in the offspring [40, 56–58]. The acquired phenotype in these models has been
linked to reduced responsiveness to the satiety signals leptin and insulin in arcuate hypotha-
lamic neurons of juvenile as well as adult offspring [34, 35].
Here, we could demonstrate reduced receptor expression (INSR, LEPR) in three-week-old
chickens, exposed only to elevated glucose prenatally. Interestingly, while little is known on
Fig 6. Correlation analyses.Relations between total DNAmethylation levels and corresponding mRNA expression of the insulin receptor (A), leptin
receptor (B), glucose transporter 1 (C) and glucose transporter 3 (D) in the Nucleus infundibuli hypothalami (NI) in three-week-old chickens of prenatally
NaCl-treated controls (black) as compared to the prenatally glucose-treated group (gray).
doi:10.1371/journal.pone.0119213.g006
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leptinergic action in the chicken hypothalamus insulinergic function has clearly been demon-
strated [14]. As in mammals, decreased action of the satiety-signals, insulin and leptin, at the
mediobasal hypothalamus appears to favor activation of orexigenic/catabolic pathways and re-
spective neuropeptide expression [10, 14]. Moreover, the INSR and LEPR findings were accom-
panied here by clear reduction of GLUT1 and GLUT3 expression. GLUT1 is the main glucose
transporter at the blood-brain-barrier in mammals [59] while, the majority of glucose sensing
neurons use glucose transporter 3 (GLUT3) as primary transporter. These functions of brain
GLUT1 and GLUT3 seem to be very similar in birds as in mammals [31–33]. Our data, there-
fore, appears to indicate an acquired ‘diabesogenic’ predisposition at the hypothalamic mRNA
expression level of prenatally high-glucose exposed chicken.
Prenatally glucose-exposed chicken in the present study showed a significant decrease of
INSR, LEPR, GLUT1 and GLUT3, while not showing differences in plasma glucose levels, body
weight and total body fat as compared to the prenatally NaCl-exposed controls. Therefore, sup-
pression of hypothalamic anorexigenic pathways appears not to be caused here by a negative
feedback regulation within the current metabolic state but might rather be a long-term conse-
quence of temporary prenatal hyperglycemia. The lack of phenotypic ‘obesogenic’ alterations,
however, might indicate that early ‘programming’ of ‘obesity’ depends on additional exposures
rather than prenatal hyperglycemia itself. General materno-fetal overfeeding, in addition to ele-
vated glucose itself, might be crucial here, translationally in line with the ‘mixed nutrients hy-
pothesis’ [60] and observations in offspring of overweight/obese women irrespective of GDM
[52]. At the same time, this may illustrate the mechanistic value of investigations in the chicken
model for the ‘perinatal programming of diabesity’ field. Note, while our focus was primarily
on the programming linked to the critical brain region associated with physiological/metabolic
pathways and at an earlier time point of life (3 weeks of age), we understand that phenotypic al-
terations could become more prominent only in later age. For instance, investigations in genet-
ic crosses of high and low weight chicken lines, without introducing any treatment, have
reported differences in baseline parameters only at later time points (>5–11 weeks) and in spe-
cific peripheral tissues (esp. abdominal fat) without seeing changes in overall body weight [10,
61]. Normal total body weight and even total body fat in chicken does not necessarily exclude a
‘diabesogenic’ phenotype especially since abdominal fat depots seem to be particularly affected
in this species [10, 61]. Finally, in rats and humans, phenotypic expression of perinatally ac-
quired diabesity disposition has translationally be shown to occur only at later juvenile and
adult age or even after an early age ‘recovery’ [36, 62, 63].
Surprisingly, clearly altered expression of INSR, LEPR, GLUT1 and GLUT3 did not coincide
with nor were explainable by alterations of respective promoter DNAmethylation patterns as
indicated with a lack of negative correlation between gene expression and methylation levels at
either individual CpG sites or overall average across a promoter region amplicon (Fig. 6). Ac-
cordingly, further reflection on potential causes arise from the methodological design of our
study and/or mechanisms other than altered promoter methylation acquired through prenatal
high-glucose exposure. Regarding the genomic regions selected for methylation analyses, most
of the investigated promoter region CpG islands encompassed the 5’UTR, as well as the first
exon and intron (LEPROT, GLUT1 and GLUT3), with the exception of the CpG island located
approximately 2 KB upstream of the start of INSR. The chicken INSR locus, in particular, is not
well annotated and under-examined in comparison to mammals. Conservation across species
(e.g. human and rodent) was therefore considered and revealed a substantial lack of conserva-
tion at these chicken CpG island regions. It was previously reported that chicken GLUT1 and
GLUT3 have 80.4% and 70.4% amino acid sequence homology with human GLUT1 and
GLUT3, respectively [64]. Chicken and human LEPR have 47.2% amino acid sequence homol-
ogy [29] and the INSR amino acid sequence homology of chicken and human depends on the
Prenatal Hyperglycemia and Hypothalamic Malprogramming
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domain investigated [65], with considerable high ranges of 69% up to 93% based on C-termi-
nal, juxtamembrane and tyrosine kinase domains. Despite the degree of homology at the
amino acid level, low to no conservation between human and chicken at 5’UTRs and start sites
was observed and reported as compared to exon sequences [17]. Functional elements in the
chicken-human alignment are reduced in contrast to the human-mouse-rat alignments [17].
An interesting suggested difference in the bird is the absence of the epigenetic phenomenon of
genomic imprinting, with known imprinted genes in mammals showing biallelic expression in
chicken [66, 67]. In addition, DNMT3L, which is essential for the establishment of imprinting
marks as demonstrated in the mouse, has not been identified in chicken further implying that
genomic imprinting as seen in mammals may not occur in birds [68, 69]. In general, Head
et al. reported approximately 56% of CpG sites in the chicken brain are methylated, versus ap-
proximately 70% in mammals [70]. On the other hand, while there is a growing interest in the
epigenetic patterns in the chicken [71], not much has been reported so far on methylation lev-
els at gene specific promoter regions examined in our study. Recently, Nätt et al. addressed po-
tential brain promoter methylation related sex differences according to behavior, and observed
few [72]. Authors reported even up-regulation of the Zinc Finger RNA binding protein (ZHR)
gene despite hypermethylation, which they discussed, might indicate a novel epigenetic regula-
tory mechanism CG independent or, perhaps, could be from non-CpG-sequence methylation.
Non-CpG methylation was observed to be particularly prevalent in the adult human and in
mouse brain [73] and specifically more abundant in neuronal compared with non-neuronal
cells [74] however; non-CpG methylation has yet to be fully investigated in the bird. A growing
consideration is that non-CpG methylation could provide insight in understanding the mecha-
nisms of cell-type-specific gene expression in the brain.
Beyond methylation-related gene expression and gene expressivity, chromatin structure
and looping of locus control regions (involving enhancer elements) regulate chicken genes
with distinct temporal expression patterns. Additionally, histone modifications in respective
domains (e.g. BETA-GLOBIN) are thought to modulate the ‘open’ or ‘closed’ chromatin con-
formation allowing for enhancer elements to act to regulate expression in a tissue/cell-type and
developmental time point specific manner [75]. These mechanisms appear to be relevant trans-
lationally, i.e., over species, but not comprehensively characterized so far in birds. Non-coding
RNA and anti-sense transcripts could be acting to regulate expression. Non-coding RNAs are
conserved in the bird which could hint to their mechanistic role having greater importance in
chicken compared to other species [17].
Finally, beyond addressing above mentioned alternative epigenomic aspects in future stud-
ies, potential microstructural as well as regulatory causes should also be considered when inter-
preting our observations. First, as indicated by respective positive correlations GLUT1 and
GLUT3mRNA decrease might be a result, at least in part, of decreased INSR and LEPR expres-
sion. GLUT expression regulation downstream of the insulin- and leptin receptor is well estab-
lished [31–33, 59], while acquired hypothalamic resistance to insulin and leptin, resulting from
pre- and perinatal high-glucose exposure and overfeeding, has been shown in rats [34–37] and
functionally been indicated even in the human [38]. Also, microstructural disorganization has
been proposed and shown to be a second critical and general mechanism of prenatal, especially
central nervous, imprinting and programming [4, 76]. For instance, final number and numeri-
cal density of neurons in mediobasal hypothalamic nuclei have been shown to become altered
through prenatal exposure to elevated glucose levels [36, 37, 57, 62, 77], potentially contribut-
ing to overall altered mRNA levels in the ARC/NI. Though the primary focus of this study was
the ARC/NI, we do suggest that neighbouring regions, e.g. ventromedial hypothalamic nucleus,
[37, 77–82] could also be affected by prenatal high-glucose exposure, and maybe even with
epigenomic modifications.
Prenatal Hyperglycemia and Hypothalamic Malprogramming
PLOS ONE | DOI:10.1371/journal.pone.0119213 March 26, 2015 14 / 19
In summary, temporary exposure to high glucose levels in late prenatal life of chicken, irre-
spective of and without any other developmental alterations, gave rise to reduced INSR, LEPR,
GLUT1 and GLUT3mRNA expression in the ARC/NI hypothalamic region. This speaks for an
acquired alteration of the molecular ‘set-point’ and continuous suppression through prenatal
exposure to hyperglycemia. Data therefore may indicate in a translational sense that elevated
glucose acts as a ‘metabolic disruptor’ during central nervous development, leading to a persis-
tent malprogramming at the expression level of candidate genes addressed here. At the same
time, absence of related changes in promoter DNAmethylation seems to challenge an over-
simplified favoring of respective promoter epigenomics as the principle and only mechanism
in prenatal imprinting and central nervous programming.
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